02/18/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:05 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/28/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
6:30 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
6:00 AM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:00 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
3:01 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
4:06 PM | Bay Shore Trust (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
12:37 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:37 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Jerman Michael Allen (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
10:17 AM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2024
3:31 PM | Telomir Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/29/2024
4:28 PM | Telomir Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
